Target intelligence / Profile preview

Retinol dehydrogenase 13 (RDH13)

Target
RDH13
Molecular classification
Enzyme, Short-chain dehydrogenase/reductase, Mitochondrial protein
01

Overview

Retinol dehydrogenase 13 (RDH13) is a mitochondrial NADP(^+)-preferring enzyme of the short-chain dehydrogenase/reductase family, primarily acting as a retinaldehyde reductase. RDH13 is expressed widely in human tissues, localized to the outer side of the inner mitochondrial membrane, and is thought to protect mitochondria against oxidative stress caused by reactive retinoid metabolites. It shows highest catalytic efficiency for the reduction of all-trans-retinaldehyde using NADPH, but has very weak oxidase activity for retinol, and does not act on steroids. RDH13 is conserved across vertebrate species and may contribute to retinoic acid homeostasis, with potential disease relevance in retinal and developmental pathologies

Other names
RDH13SDR7C3Short chain dehydrogenase/reductase family 7C member 3Retinol dehydrogenase 13 (all-trans and 9-cis)Retinol dehydrogenase 13 (all-trans/9-cis)EC 1.1.1.300
02

Mechanism of action

Not directly targeted by pharmaceutical agents; general mechanism involves catalysis of retinoid reactions (e.g., reduction of all-trans-retinaldehyde to all-trans-retinol in the presence of NADPH), protecting mitochondria from reactive aldehyde

03

Biological functions

Retinoid metabolismOxidoreductase activity (reduction of retinaldehyde and oxidation of retinol)Protection of mitochondria against oxidative stress
04

Disease associations

Retinal disorders (e.g., Fundus albipunctatus; possible association)Noonan syndrome 10 (reported association)Other (possible implication in general oxidative stress biology, but not directly established in specific diseases)

Beyond the preview

Go deeper on Retinol dehydrogenase 13 (RDH13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinol dehydrogenase 13 (RDH13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call